Atlas Trials

Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer

Clinical trial NCT06338683 · RECRUITING

Trial details

NCT number
NCT06338683
Sponsor
Qinghai Red Cross Hospital
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Advanced CancerOlanzapineProgression Free Survival
Start date
2024-03-20
Primary completion
2027-03-20
Enrollment
230

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.